BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10850863)

  • 21. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
    Wellenreuther R; Kraus JA; Lenartz D; Menon AG; Schramm J; Louis DN; Ramesh V; Gusella JF; Wiestler OD; von Deimling A
    Am J Pathol; 1995 Apr; 146(4):827-32. PubMed ID: 7717450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF2 mutations in secretory and other rare variants of meningiomas.
    Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A
    Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial meningioma is not allelic to neurofibromatosis 2.
    Pulst SM; Rouleau GA; Marineau C; Fain P; Sieb JP
    Neurology; 1993 Oct; 43(10):2096-8. PubMed ID: 8413972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
    Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
    Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features.
    Goutagny S; Bah AB; Henin D; Parfait B; Grayeli AB; Sterkers O; Kalamarides M
    Neuro Oncol; 2012 Aug; 14(8):1090-6. PubMed ID: 22711605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of allelic losses and telomerase activity in meningiomas.
    Leuraud P; Dezamis E; Aguirre-Cruz L; Taillibert S; Lejeune J; Robin E; Mokhtari K; Boch AL; Cornu P; Delattre JY; Sanson M
    J Neurosurg; 2004 Feb; 100(2):303-9. PubMed ID: 15098535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study.
    Buccoliero AM; Castiglione F; R Degl'Innocenti D; Gheri CF; Garbini F; Taddei A; Ammannati F; Mennonna P; Taddei GL
    Neuropathology; 2007 Feb; 27(1):36-42. PubMed ID: 17319281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and molecular characteristics of pediatric meningiomas.
    Battu S; Kumar A; Pathak P; Purkait S; Dhawan L; Sharma MC; Suri A; Singh M; Sarkar C; Suri V
    Neuropathology; 2018 Feb; 38(1):22-33. PubMed ID: 28901666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration.
    Teranishi Y; Miyawaki S; Nakatochi M; Okano A; Ohara K; Hongo H; Ishigami D; Sakai Y; Shimada D; Takayanagi S; Ikemura M; Komura D; Katoh H; Mitsui J; Morishita S; Ushiku T; Ishikawa S; Nakatomi H; Saito N
    Acta Neuropathol Commun; 2023 Sep; 11(1):156. PubMed ID: 37752594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
    Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
    Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
    Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
    J Neurosurg; 2020 May; 134(5):1377-1385. PubMed ID: 32442973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas.
    Tabernero M; Jara-Acevedo M; Nieto AB; Caballero AR; Otero A; Sousa P; Gonçalves J; Domingues PH; Orfao A
    BMC Med Genet; 2013 Oct; 14():114. PubMed ID: 24171707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of genetic and epigenetic changes in meningiomas without NF2 loss.
    van Tilborg AA; Morolli B; Giphart-Gassler M; de Vries A; van Geenen DA; Lurkin I; Kros JM; Zwarthoff EC
    J Pathol; 2006 Mar; 208(4):564-73. PubMed ID: 16353169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
    Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
    Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
    Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
    Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas.
    Joachim T; Ram Z; Rappaport ZH; Simon M; Schramm J; Wiestler OD; von Deimling A
    Int J Cancer; 2001 Oct; 94(2):218-21. PubMed ID: 11668501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characteristics of meningiomas in a cohort of Indian patients: loss of heterozygosity analysis of chromosomes 22, 17, 14 and 10.
    Asirvatham JR; Pai R; Chacko G; Nehru AG; John J; Chacko AG; Muliyil J
    Neurol India; 2013; 61(2):138-43. PubMed ID: 23644312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma.
    Baser ME; Poussaint TY
    J Med Genet; 2006 Mar; 43(3):285-7. PubMed ID: 15980114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.